Avaleht › Leukeemia › Illinois › Chicago
Leukeemia kliinilised uuringud linnas Chicago, IL
16 uuringut haiguse Leukeemia jaoks otsivad osalejaid linnas Chicago ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
VärbamineFaas 1/2
- The University of Chicago Medical Center, Chicago
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
VärbamineFaas 3
- Research Site, Chicago
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
VärbamineFaas 1/2
- University of Chicago, Chicago
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
VärbamineFaas 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
VärbamineFaas 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
VärbamineFaas 1/2
- Research Site, Chicago
Mosaic Trial for Stem Cell Transplant Recipients
Värbamine
- Northwestern University Feinberg School of Medicine, Chicago
Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)
VärbamineFaas 2
- University of Chicago Medical Center, Chicago
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
VärbamineVaatlusuuring
- Lurie Children's Hospital-Chicago, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
VärbamineFaas 1/2
- University of Illinois at Chicago Cancer Center, Chicago
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
VärbamineFaas 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia
Värbamine
- UChicago Medicine Comprehensive Cancer Center, Chicago
CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
VärbamineFaas 1/2
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Värbamine
- University of Chicago Comprehensive Cancer Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
VärbamineVaatlusuuring
- Massive Bio SYNERGY-AI site, Chicago
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
VärbamineFaas 1
- Northwestern Medicine - Northwestern Memorial Hospital Galter Pavilion, Chicago
Leukeemia uuringud teistes linnades
- Houston, TX28 uuringut
- Boston, MA25 uuringut
- New York City, NY19 uuringut
- Los Angeles, CA16 uuringut
- Durham, NC13 uuringut
- Baldwin Park, CA12 uuringut
- Columbus, OH12 uuringut
- Nashville, TN12 uuringut
- Philadelphia, PA12 uuringut
- Milwaukee, WI11 uuringut
- Atlanta, GA11 uuringut
- Seattle, WA11 uuringut
Muud uuringud linnas Chicago
- Mitteväikerakuline kopsuvähk61 uuringut
- Rinnavähk58 uuringut
- Vähk (kõik liigid)51 uuringut
- Metastaatiline vähk45 uuringut
- Eesnäärmevähk45 uuringut
- Rasvumine41 uuringut
- Kopsuvähk41 uuringut
- Munasarjavähk36 uuringut
- Insult34 uuringut
- Käär- ja pärasoolevähk33 uuringut
- Südamepuudulikkus31 uuringut
- Ülekaalulisus28 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.